Insys Therapeutics, Inc. Receivables Turnover Ratio (INSY), from the first quarter 2019 to the first quarter 2018 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Insys Therapeutics, Inc.  (INSY)
 

Insys Therapeutics Accounts Receivables Turnover Ratio from the first quarter 2019 to the first quarter 2018

Quarterly Results, Trends, Rankings, Statistics


Insys Therapeutics, Inc.'s ability to collect accounts receivable sequentially worsen to 5.11, indicating more challenging environment then in the fourth quarter 2018, but still, it is a far cry from any concerns. Insys Therapeutics's Accounts Receivable average collection period in the Mar 31 2019 quarter, has increased to 71 days, from 68 days, in the Dec 31 2018 quarter.

If we take a look into Healthcare sector 341 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Mar 31 2019 from 2688 to 2690.

What is Receivable Turnover Ratio?
What is Insys Therapeutics, Inc. Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

INSY Receivables Turnover Ratio (Mar 31 2019)
I. Quarter		 (Dec 31 2018)
IV. Quarter		 (Sep 30 2018)
III. Quarter		 (Jun 30 2018)
II. Quarter		 (Mar 31 2018)
I. Quarter
Y / Y Receivable Change -61.38 % -41.38 % -45.3 % -16.29 % 18.39 %
Y / Y Revenue Change -68.09 % -48.05 % -40.18 % -44.88 % -33.51 %
Receivable Turnover Ratio (TTM) 5.11 5.37 5.55 5.44 6.09
INSY's Total Ranking # 2690 # 2688 # 2898 # 2688 # 2898
Accounts Receivable average collection period days 71 68 66 67 60
Seq. Receivable Change -51.73 % -0.84 % -36.63 % 27.32 % -26.74 %
Seq. Revenue Change -53.35 % -10.84 % -21.82 % -1.86 % -24.06 %


Receivable Turnover Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 100
Healthcare Sector # 342
Overall Market # 2690

Receivable Turnover Ratio Statistics
High Average Low
1.44 0.82 0.32
(Dec 31 2014)   (Mar 31 2019)





INSY Company Profile • Back to INSY Efficiency Comparisons • Compare INSY Receivables Turnover Ratio to its Competitors

Financial Statements
Insys Therapeutics's Accounts Receivable $ 6 Millions Visit INSY's Balance sheet
Insys Therapeutics's Sales TTM $ 66 Millions Visit INSY's Income Statement
Sources of INSY's Revenues Visit INSY's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
INSY's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
INSY's Growth Rates INSY's Roa INSY's Inventory Turnover Ratio INSY's Dividend Comparisons
INSY's Profitability Ratios INSY's Roi INSY's Asset Turnover Ratio INSY's Dividend Growth
INSY's Valuation Ratios INSY's Roe INSY's Financial Strength Ratios INSY's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2019, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Mar 31 2019 Receivable at quarter ending Mar 31 2019
Fibrocell Science, Inc.  27.84 $ 2.046  Millions$ 0.074  Millions
Logicmark Inc  27.72 $ 16.368  Millions$ 0.591  Millions
Dariohealth Corp   27.60 $ 7.880  Millions$ 0.286  Millions
Arrowhead Pharmaceuticals Inc   26.91 $ 94.789  Millions$ 3.523  Millions
Momenta Pharmaceuticals inc   26.33 $ 74.850  Millions$ 2.843  Millions
Harrow Inc   24.89 $ 44.797  Millions$ 1.800  Millions
Agenus Inc  24.58 $ 115.039  Millions$ 4.681  Millions
Axim Biotechnologies Inc   24.05 $ 0.198  Millions$ 0.008  Millions
Acadia Healthcare Company Inc   23.36 $ 7,735.589  Millions$ 331.213  Millions
Creative Medical Technology Holdings Inc   23.19 $ 0.166  Millions$ 0.007  Millions
Health right Discoveries Inc   23.14 $ 5.403  Millions$ 0.234  Millions
Zeo Scientifix Inc   23.08 $ 0.992  Millions$ 0.043  Millions
Ernexa Therapeutics Inc   22.08 $ 22.390  Millions$ 1.014  Millions
Spero Therapeutics Inc   21.51 $ 10.531  Millions$ 0.490  Millions
Geovax Labs Inc   20.87 $ 1.549  Millions$ 0.074  Millions
Vtv Therapeutics Inc   19.90 $ 11.291  Millions$ 0.568  Millions
Tearlab Corp  19.76 $ 24.083  Millions$ 1.219  Millions
Plx Pharma Inc   19.47 $ 0.989  Millions$ 0.051  Millions
Seres Therapeutics Inc   18.97 $ 31.617  Millions$ 1.667  Millions
Premier Biomedical Inc  18.89 $ 0.035  Millions$ 0.002  Millions
Endonovo Therapeutics Inc   18.38 $ 0.121  Millions$ 0.007  Millions
Immunogen inc   18.14 $ 44.030  Millions$ 2.428  Millions
Cv Sciences Inc   18.07 $ 55.084  Millions$ 3.048  Millions
Traws Pharma inc   17.64 $ 0.732  Millions$ 0.041  Millions
Fortress Biotech Inc   17.39 $ 142.995  Millions$ 8.223  Millions
Valion Bio Inc   17.31 $ 0.264  Millions$ 0.015  Millions
Regenxbio Inc   17.12 $ 86.998  Millions$ 5.081  Millions
Fate Therapeutics Inc   16.92 $ 6.346  Millions$ 0.375  Millions
Healthlynked Corp  16.71 $ 2.078  Millions$ 0.124  Millions
Imac Holdings Inc   16.66 $ 2.770  Millions$ 0.166  Millions

Date modified: 2026-08-29T17:20:56+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.